The store will not work correctly in the case when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Biological Data Biological description BET bromodomain inhibitor. Inhibits cytokine-induced transcription of STAT targets and downregulates cytokine production. Shows anti-inflammatory and anti-cancer actions. Promotes differentiation of hiPSCs into megakaryocytes.
Solubility & Handling Storage instructions -20°C
Solubility overview Soluble in DMSO (100mM) or ethanol (100mM)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.
Chemical Data Chemical name 7-(3,5-Dimethyl-4-isoxazolyl)-1,3-dihydroxy-8-methoxy-1-[(1R )-1-(2-pyridinyl)ethyl]-2H -imidazo[4,5-c ]quinolin-2-one hydrochloride
Chemical structure
Molecular Formula C23 H21 N5 O3 .HCl
PubChem identifier 170320
SMILES O=C(N3[C@H](C)C4=NC=CC=C4)NC2=C3C1=CC(OC)=C(C5=C(C)ON=C5C)C=C1N=C2.Cl.Cl
InChiKey IQOJZZHRYSSFJM-UHFFFAOYSA-N
References for I-BET 151 hydrochloride References are publications that support the biological activity of the product
BET bromodomain inhibition suppresses transcriptional responses to cytokine-Jak-STAT signaling in a gene-specific manner in human monocytes. Chan CH et al (2015) Eur J Immunol 45(1) : 287-97. The BET Bromodomain Inhibitor I-BET151 Acts Downstream of Smoothened Protein to Abrogate the Growth of Hedgehog Protein-driven Cancers. Long J et al (2014) J Biol Chem 289(51) : 35494-502. Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151. Gallagher SJ et al (2014) Pigment Cell Melanoma Res 27(6) : 1126-37.
Tell us about your publication! What Hello Bio product(s) have you cited?
Captcha Please type the letters and numbers below Submit
BET bromodomain inhibitor, also promotes differentiation of hiPSCs into megakaryocytes